HBV-active ART will reduce this cycle through inhibition of both HIV and HBV replication, however given CXCL10 remains elevated on ART, this pathway may also be important in driving liver disease on treatment and requires further investigation. This evidence concerns the gene CXCL10 and liver disorder.